(MDVL) – Globe Newswire
-
MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters
-
MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q
-
MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCenters
-
MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference
-
MedAvail Reports Second Quarter 2023 Financial Results
-
MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters
-
MedAvail Announces 1-for-50 Reverse Stock Split
-
MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources
-
MedAvail Reports First Quarter 2023 Financial Results
-
MedAvail to Report First Quarter 2023 Financial Results on May 18
-
MedAvail Postpones Reporting of First Quarter 2023 Financial Results
-
MedAvail to Report First Quarter 2023 Financial Results on May 15
-
MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
-
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
-
MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results
-
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
-
MedAvail Announces Closing of $16 Million Private Placement
-
MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy
-
MedAvail announces Strategic Restructuring of Business to Focus on Profitability
-
MedAvail Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
-
MedAvail Ranked in the Top 500 Fastest-Growing Companies in North America
-
MedAvail Reports Third Quarter 2022 Financial Results
Back to MDVL Stock Lookup
